Walleye Capital
UPC icon

Walleye Capital’s Universe Pharmaceuticals Inc UPC Stock Holding History

Walleye Capital’s Portfolio UPC Stock Details UPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$50 – 2328
2021
Q3 		$50 Buy
+6
New +$55.2K ﹤0.01% 1394

Other funds holding UPC

PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Capital's UPC Position: Q4 2021 in Review

Walleye Capital sold out of Universe Pharmaceuticals Inc (UPC) in Q4 2021, closing a stake of 6 shares — an estimated $50 sold.

Walleye Capital first reported a position in UPC in Q3 2021 and held it in 1 quarter. The position peaked at $50 in Q3 2021. 5 funds tracked by Wall St. Rank hold UPC as of Q4 2021.

  • Walleye Capital reported no remaining Universe Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Walleye Capital sold 6 Universe Pharmaceuticals Inc shares in Q4 2021, an estimated $50.
  • Walleye Capital first reported a position in Universe Pharmaceuticals Inc in Q3 2021 and held it in 1 quarter.
  • Walleye Capital's Universe Pharmaceuticals Inc position peaked at $50 in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q4 2021.

Based on Walleye Capital's 13F filing for Q4 2021, filed 3 Mar 2022.